Results 1 to 10 of about 26,349,951 (265)
Some of the next articles are maybe not open access.
The correlation between serum SPINK1 and CA 15-3
Clinica Chimica Acta, 2019I.W. Masfufa, M. Fattah
openaire +1 more source
Comparison of the tumor markers CA 19–9, CA 12–5, CA 15–3 and CA 50
Journal of Cancer Research and Clinical Oncology, 1986C. Dienst, F. -G. Hanisch, G. Uhlenbruck
openaire +1 more source
[CA 15-3 in breast cancer--specificity and diagnostic potential].
Bollettino della Societa italiana di biologia sperimentale, 1988ZITO GA +8 more
openaire +2 more sources
Tumor antigens CA 125 and CA 15-3 as markers of endometrial adenocarcinoma.
The Journal of nuclear medicine and allied sciences, 1991L, Babilonti +5 more
openaire +1 more source
[CA 15-3--a tumor marker in breast cancer].
Harefuah, 1994A D, Cohen, Y, Cohen, Y, Shoenfeld
openaire +1 more source
CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia [PDF]
Scientific Reports, 2022 The severity of lung involvement is the main prognostic factor in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Carbohydrate antigen 15-3 (CA 15-3), a marker of lung damage and fibrosis, could help predict the prognosis of SARS ...
José Antonio Ros-Lucas +16 more
doaj +8 more sources
Longitudinal evaluation of external quality assessment results for CA 15-3, CA 19-9, and CA 125 [PDF]
Frontiers in Molecular BiosciencesBackgroundTumor markers are established laboratory tools that help to diagnose, estimate prognosis, and monitor the course of cancer. For meaningful decision-making in patient care, it is essential that methods and analytical platforms demonstrate high ...
Marcel Kremser +8 more
doaj +6 more sources
CA 15–3: A Prognostic Marker in Breast Cancer
The International Journal of Biological Markers, 2000 CA 15–3 (also known as MUC1) is the most widely used serum marker in breast cancer. MUC1 is a large transmembrane glycoprotein which is frequently overexpressed and aberrantly glycosylated in cancer.
M.J. Duffy +4 more
doaj +4 more sources